- We will send in 10–14 business days.
/images/books/2809019/9780081010112.jpg)
- Publisher: Elsevier
- ISBN-10: 0081010117
- ISBN-13: 9780081010112
- Format: 19.1 x 23.5 x 1.9 cm, minkšti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Design of Hybrid Molecules for Drug Development (e-book) (used book) | bookbook.eu
Reviews
Description
Design of Hybrid Molecules for Drug Development reviews the principles, advantages, and limitations involved with designing these groundbreaking compounds. Beginning with an introduction to hybrid molecule design and background as to their need, the book goes on to explore a range of important hybrids, with hybrids containing natural products, molecules containing NO- and H2S-donors, dual-acting compounds acting as receptor ligands and enzyme inhibitors, and the design of photoresponsive drugs all discussed.
Drawing on practical case studies, the hybridization of molecules for development as treatments for a number of key diseases is then outlined, including the design of hybrids for Alzheimer's, cancer, and malaria.
With its cutting-edge reviews of breaking developments in this exciting field, the book offers a novel approach for all those working in the design, development, and administration of drugs for a range of debilitating disorders.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 23d.09:04:31
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Elsevier
- ISBN-10: 0081010117
- ISBN-13: 9780081010112
- Format: 19.1 x 23.5 x 1.9 cm, minkšti viršeliai
- Language: English English
Design of Hybrid Molecules for Drug Development reviews the principles, advantages, and limitations involved with designing these groundbreaking compounds. Beginning with an introduction to hybrid molecule design and background as to their need, the book goes on to explore a range of important hybrids, with hybrids containing natural products, molecules containing NO- and H2S-donors, dual-acting compounds acting as receptor ligands and enzyme inhibitors, and the design of photoresponsive drugs all discussed.
Drawing on practical case studies, the hybridization of molecules for development as treatments for a number of key diseases is then outlined, including the design of hybrids for Alzheimer's, cancer, and malaria.
With its cutting-edge reviews of breaking developments in this exciting field, the book offers a novel approach for all those working in the design, development, and administration of drugs for a range of debilitating disorders.
Reviews